Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Lung Neoplasms, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Recurrence, Sarcoma, Kaposi, HIV Infections

NCT03993327 2024-06-28

An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer

Phase 1 Completed

4 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03311828 2024-03-12

Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma

Phase 1 Completed

12 enrolled

Plasma cell

Multiple Myeloma

NCT03565367 2023-12-21

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors

Phase 1 Completed

9 enrolled 6 charts

CNS

Central Nervous System Neoplasms

NCT03493789 2023-10-18

Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy

Phase 1 Completed

19 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00880074 2023-06-26

FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies

Phase 1 Completed

10 enrolled

Tumor-Agnostic

Neoplasms

NCT04216134 2023-06-15

68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

Phase 1 Completed

19 enrolled

Genitourinary

Biochemically Recurrent Prostate Carcinoma

NCT01918644 2022-06-01

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

Phase 1 Completed

21 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01143779 2022-01-04

FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib

Phase 1 Completed

3 enrolled

Advanced Cancer

NCT02146222 2019-11-18

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

Phase 1 Completed

14 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01028885 2019-07-25

MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate

Phase 1 Completed

10 enrolled

Genitourinary

Prostatic Neoplasms

NCT01537107 2019-04-08

Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery

Phase 1 Completed

31 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT01561014 2018-07-02

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Phase 1 Completed

9 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT00599755 2018-01-16

Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)

Phase 1 Completed

68 enrolled 12 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT00610493 2017-12-08

Bevacizumab and Temsirolimus in Patients With Advanced Malignancy

Phase 1 Completed

193 enrolled

Advanced Cancer

NCT00499135 2017-10-10

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Phase 1 Completed

25 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00019565 2016-09-26

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

Phase 1 Completed

53 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01320059 2016-06-27

Study of 18F-Fluoro-PEG6-IPQA

Phase 1 Completed

6 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00605397 2015-12-28

Cu-64 HER2+

Phase 1 Completed

11 enrolled

Breast

Breast Neoplasms

NCT00039286 2015-12-24

Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer

Phase 1 Completed

118 enrolled

Breast

Breast Neoplasms

NCT00109785 2015-12-24

PET Scans in Patients With Locally Advanced Breast Cancer

Phase 1 Completed

8 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00121264 2014-06-17

17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

54 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00769288 2014-01-07

FAU in Treating Patients With Advanced Solid Tumors or Lymphoma

Phase 1 Completed

12 enrolled

DermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

NCT00003410 2013-06-26